US Stocks
ALGS

Aligos Therapeutics, Inc. Common Stock

$7.67
+0.26 (+3.56%)

Volume:

6.114K ($46.89K)

Market Capitalization:

$41.32M

Aligos Therapeutics Price Chart

Aligos Therapeutics Price Chart 6:50 PM 4:10 AM 5:30 AM 6:50 AM 8:10 AM 9:30 AM 10:50 AM7.837.797.747.707.657.617.56

Aligos Therapeutics Volume Chart

Aligos Therapeutics Volume Chart 6:50 PM4:10 AM5:30 AM6:50 AM8:10 AM9:30 AM10:50 AM 3.48K2.98K2.49K1.99K1.49K994497

Aligos Therapeutics Market Segments

Regular Trading Hours

+0.11(+1.43%)
Open$7.56
Close$7.67
Low$7.56
Low Change0.00 (0.00%)
High$7.83
High Change+0.27 (+3.55%)
Range$0.27
Volume6.114K
Dollar Volume$46.89K

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.20(-2.68%)
Open$7.61
Close$7.41
Low$7.20
Low Change-0.41 (-5.39%)
High$7.62
High Change+0.01 (+0.13%)
Range$0.42
Volume17.982K
Dollar Volume$133.17K

Premarket Yesterday

+0.00(+0.00%)
Open$7.97
Close$7.97
Low$7.97
Low Change0.00 (0.00%)
High$7.97
High Change+0.00 (+0.00%)
Range$0.00
Volume133
Dollar Volume$1.06K

Aligos Therapeutics Moving Averages

5 Day Moving Average (SMA5)$7.17
10 Day Moving Average (SMA10)$7.00
20 Day Moving Average (SMA20)$7.01
50 Day Moving Average (SMA50)$7.80
100 Day Moving Average (SMA100)$8.55
200 Day Moving Average (SMA200)$8.59

Aligos Therapeutics Statistics

Average Volume (30 Days)45.79K
P/E Ratio (Current)-1.93
EPS (Current)-$3.93
Dividend Yield0.00%
Free Cash Flow-$82.94M
Cash Ratio0.86
Current Ratio3.90
Quick Ratio3.90
Debt to Equity0.00
Enterprise Value$28.47M
EV to EBITDA-0.33
EV to Sales13.02
Price to Book0.87
Price to Cash Flow
Price to Free Cash Flow
Price to Sales21.31
Return on Assets-0.27%
Return on Equity-0.45%

Aligos Therapeutics Stock Splits

There has been 1 stock split for Aligos Therapeutics (ALGS). The reverse stock split occured on August 19, 2024 and reduced the outstanding shares at a ratio of 25:1.

DateTypeRatio
Aug 19, 2024Reverse25:1

Aligos Therapeutics Dividends

There have been no dividends for Aligos Therapeutics (ALGS).